Investor Ideas #Potcasts; #Cannabis News
and Stocks on the Move; TSXV: $N.V,
TSXV: $KHRN.V, TSX: $TRST.TO, TSX: $ACB.TO, TSXV: $ICC.V
Pt. Roberts, WA; Delta, BC –June 13, 2018
(Investorideas.com Newswire) www.Investorideas.com, a global news source covering
leading sectors including marijuana and hemp stocks and its “potcast’ site, www.potcasts.ca release today’s edition of
its new series, Investorideas.com potcastsCM - cannabis news and stocks to
watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full at http://www.investorideas.com/news/2018/cannabis/06139Potcasts-TSXVNKHRNTRSTACBICC.asp
Today’s podcast overview/transcript:
Good afternoon and welcome to another Investorideas.com potcast; looking
at cannabis news, stocks to watch as well as insights from thought leaders and
experts. Today we have news announcements from Namaste Technologies Inc. (TSX-: N), Khiron Life Sciences Corp. (TSX-V: KHRN) , CannTrust Holdings Inc ( TSX:
TRST) , Aurora
Cannabis Inc. (TSX: ACB , OTCQB : ACBFF ) and ICC Labs Inc. (TSX-V: ICC).
Namaste
Technologies Inc. announced that further to its April 25th, 2018
announcement of a Letter of Intent with Pineapple Express Delivery Inc., the
Company has signed a Subscription Agreement to acquire 15% of the share capital
of Pineapple Express Delivery Inc. for $1,000,000. Additionally, Namaste
is pleased to announce that Pineapple Express Delivery Inc. has secured a
Courier Services Agreement with Ample Organics, Canada's leading seed-to-sale
software platform, for same-day cannabis delivery. Both transactions validate
Namaste's position as a leader in cannabis focused technology platforms, and
further demonstrate Namaste's ability to identify these value-added services
aimed at enhancing the user experience. Namaste is optimistic about its equity
investment in Pineapple Express Delivery Inc. and expects to see an immediate
impact to the overall business operation.
Khiron Life
Sciences Corp., a Canadian integrated medical cannabis company with its core
operations in Colombia, announced today that the Company has been registered by
the Colombian Agricultural Institute ("ICA") as an agronomical unit.
Khiron is one of two companies in Colombia to receive this registration.
As a
mandatory requirement for commercializing medical cannabis products in Colombia
for distribution, this milestone positions Khiron to receive the first
allocation of quota to commence commercial cultivation of high THC strains, and
to commence commercial cultivation and production of CBD strains which do not
require quota.
CannTrust
Holdings Inc., one of Canada's leading licensed producers of medical cannabis,
announced the signing of an agreement with Kwantlen Polytechnic University
(KPU) to collaborate on the ongoing development of the university's
non-academic Cannabis Career Training program.
CannTrust,
in partnership with KPU, will assist in the continued development of the
Cannabis Career Training program, with the aim of providing students with the
necessary work skills required for the industry's continually evolving demands.
Delivered in an online format, the program is easily accessible and is in
extremely high demand all across Canada.
Aurora
Cannabis Inc. announced today that it intends to complete a $7 million
investment in Choom Holdings Inc., trading on the CSE as CHOO, whereby Aurora
will receive 9,859,155 common shares from Choom's treasury, priced at $0.71 per
share, representing an 8% ownership interest.
Choom
currently operates two late stage applicants under the Access to Cannabis for Medical Purposes Regulations
("ACMPR"). Choom has agreements in place to acquire two additional
late-stage applicant craft growers in BC and Saskatchewan, including a facility
in Sooke, British Columbia, anticipated to receive its cultivation license from
Health Canada in the third quarter of 2018.
ICC Labs
Inc. announced that KSK Labs, a 100% subsidiary of Global Group Kalapa, of
which ICC Labs recently acquired 25%, subject to TSX Venture Exchange approval,
has closed a presale agreement with a Spain-based company, VenPharma, in order
to distribute cannabidiol (“CBD”) products in Spanish pharmacies and
drugstores.
VenPharma is
a laboratory specialized in natural medicine since its foundation in 1976, with
more than 1,300 points of sales in Spain. The agreed first order is of 140,000
CBD products between sublingual CBD oils of 2% and 10%, CBD creams and
infusions based on hemp, to be distributed through 500 point of sales. The
intention with the next orders is to sell over than 370,000 CBD products
annually through all the 1,300 points of sales.
Investor ideas reminds all listeners to read
our disclaimers and disclosures on the Investorideas.com website and this
podcast is not an endorsement to buy products or services or securities.
Investors are reminded all investment involves risk and possible loss of
investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also available on
iTunes, Google Play Music, Stitcher and Tunein.
Potcasts is now a certified word
mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires
Big Ideas
Investorideas.com is
a meeting place for global investors, featuring news, stock directories, video,
company profiles, interviews and more in leading sectors.
Investorideas.com
cannabis/marijuana and hemp content now includes http://cannabisstocknews.blogspot.com on Blogger.com: the
Investorideas.com news and stock directory pages, a cannabis investor group on
Linkedin.com , the 420 Cannabis Investor ideas www.420cannabisinvestorideas.com, and the new AI site Global Cannabis Investing at www.Globalcannabisinvesting.com
Disclaimer/Disclosure: Investorideas.com is
a digital publisher of third party sourced news, articles and equity research
as well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.
Additional info
regarding BC Residents and global Investors: Effective September 15 2008 - all
BC investors should review all OTC and Pink sheet listed companies for
adherence in new disclosure filings and filing appropriate documents with
Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations
of each country.
To sponsor this podcast or be a guest
Contact Investorideas.com
800-665-0411
No comments:
Post a Comment